NCT00328276View on ClinicalTrials.gov

Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

December 31, 2005

Conditions
SchizophreniasPsychosesPsychotic DisordersSchizophrenic Disorders
Interventions
DRUG

Sarcosine

Trial Locations (1)

404

Department of Psychiatry, China Medical University Hospital, Taichung

All Listed Sponsors
collaborator

National Health Research Institutes, Taiwan

OTHER

collaborator

National Science and Technology Council, Taiwan

OTHER_GOV

lead

China Medical University Hospital

OTHER

NCT00328276 - Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia | Biotech Hunter | Biotech Hunter